Rabbit 4-1BB / TNFRSF9 Protein, His Tag

Proteins and Peptides

貨號 Cat. No.
41B-R52H9
規格 Size
1mg
品牌 Brand
ACROBiosystems
Species
Rabbit
Conjugate
Unconjugated
Expression System
HEK293
Tag
His Tag

Description




Source : 


Rabbit 4-1BB, His Tag (41B-R52H9) is expressed from human 293 cells (HEK293). It contains AA Val 29 - Ile 191 (Accession # G1SHD7-1).


 

Molecule : 4-1BB


 

Synonyms : TNFRSF9,4-1BB,CD137,CDw137,ILA


 

Format : Powder


 

Category : Immune Checkpoint Proteins


 

Accession : XP_008264195.1


 

Storage : -20℃


 

Shipping condition : Powder,RT


 

Molecular Weight : 18.8 kDa


 

Characteristics :


This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 18.8 kDa. The protein migrates as 27-33 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.


 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.


 

Buffer : PBS, pH7.4


 

Description :


4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.


 

References :


(1) Cooper D, et al., 2002, Eur. J. Immunol. 32 (2): 521–9.
(2) Jang, I K., et al., 1998, Biochem. Biophys. Res. Commun. (UNITED STATES) 242 (3): 613–20.
(3) Arch, R H., Thompson C B., 1998, Mol. Cell. Biol. (UNITED STATES) 18 (1): 558–65.





詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢